Genetic Counseling Market Report 2025

The genetic counseling market size has grown rapidly in recent years. It will grow from $1.73 billion in 2024 to $1.96 billion in 2025 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to increasing public awareness of genetic disorders, rising demand for personalized medicine, greater availability of genetic testing, the growing prevalence of hereditary conditions, and expanding applications in oncology.

The genetic counseling market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing awareness of genetic disorders and counseling services, rising demand in reproductive health, a growing geriatric population, expansion of genomic testing, and higher incidence of chronic and rare diseases. Major trends in the forecast period include advancements in telegenetic counseling services, development of AI-driven risk assessment tools, innovations in genetic data interpretation software, progress in personalized genomic solutions, and the emergence of direct-to-consumer genetic testing models.

The increasing demand for personalized medicine is expected to drive the growth of the genetic counseling market in the coming years. Personalized medicine involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and enhance care. The rising demand for personalized medicine is fueled by advancements in genomic technologies, which enable precise identification of genetic variations and the development of tailored treatments. Genetic counseling supports personalized medicine by offering individualized insights based on a person’s genetic profile, facilitating accurate diagnosis and informed treatment decisions. It improves patient care by guiding risk assessment, treatment planning, and preventive strategies, ultimately enhancing healthcare outcomes. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, up from 12 approvals in 2022. Thus, the growing demand for personalized medicine is propelling the genetic counseling market.

Companies in the genetic counseling market are focusing on innovative solutions, such as consumer-initiated genetic testing platforms, to improve accessibility, personalization, and early detection of health risks. These platforms allow individuals to order genetic tests directly and receive personalized insights without visiting a healthcare provider. For instance, in July 2023, Quest Diagnostics Inc., a US-based diagnostic information services company, launched Genetic Insights, a consumer-initiated genetic testing solution. This test provides individuals with actionable insights into their genetic predispositions to various conditions, accompanied by comprehensive health reports and access to professional genetic counseling. This innovation enhances convenience, supports proactive health management, and aligns with the growing popularity of direct-to-consumer (DTC) genetic testing solutions.

In March 2025, InformedDNA Inc., a US-based genetic counseling provider, acquired Coriell Life Sciences Inc. for an undisclosed amount. Through this acquisition, InformedDNA aims to integrate Coriell’s pharmacogenomic testing and clinical decision support into its DNAimpact platform, enabling broader delivery of personalized medication guidance, improved treatment outcomes, and streamlined genetic insights for patients, healthcare providers, and payors. Coriell Life Sciences Inc. is a US-based provider of pharmacogenomic services and genetic counseling.

Major players in the genetic counseling market are Labcorp Holdings Inc., Quest Diagnostics Incorporated, Natera Inc., Myriad Genetics Inc., MedGenome Diagnostics Private Limited, GeneDx LLC, Color Health Inc., Ambry Genetics Corporation, Genome Medical Inc., Lilac Insights Private Limited, InformedDNA Inc., GeneScreen Counseling Inc., Anderson Diagnostics & Labs Private Limited, MyGeneCounsel LLC, Genetic Counselling India LLP, Genomic Valley Bharat Limited, Tandem Genetics LLC, Metis Genetics LLC, Sanmati Genetic Counseling Center, and Femmenest IVF Centre Private Limited.

North America was the largest region in the genetic counseling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in genetic counseling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the genetic counseling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Genetic counseling is a service that helps individuals understand and adapt to the medical, psychological, and familial implications of genetic factors in disease. It involves evaluating the risk of inherited conditions, interpreting genetic test results, and guiding informed healthcare decisions. This process enables individuals and families to manage genetic health risks and make well-informed choices regarding their medical care.

The primary types of genetic counseling include preconception counseling, prenatal counseling, carrier screening, and cancer risk assessment. Preconception counseling is a consultation that helps individuals or couples evaluate and manage medical, genetic, lifestyle, and environmental risks prior to conception, aiming to improve pregnancy outcomes. These counseling services are typically utilized by patients such as individuals with genetic disorders, pregnant women, and relatives of patients with hereditary conditions, and are delivered via various modes, including in-person sessions and telehealth. Genetic counseling supports applications such as proactive risk assessment, genetic consultation for intent-to-treat (ITT) patients, prenatal and preconception care, pediatric care, and more, serving key end users including hospitals, clinics, diagnostic laboratories, research institutions, and others.

The genetic counseling market research report is one of a series of new reports that provides genetic counseling market statistics, including the genetic counseling industry global market size, regional shares, competitors with the genetic counseling market share, detailed genetic counseling market segments, market trends, and opportunities, and any further data you may need to thrive in the genetic counseling industry. This genetic counseling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genetic counseling market includes revenues earned by entities through clinical interpretation, hereditary risk evaluation, wellness genomics, lifestyle-based genomic advice, post-test consultation and related educational resources, data analytics platforms, patient navigation services, outcome monitoring tools, and customized screening protocols. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.